Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice

Study Identifier
P10-448
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Rheumatoid Arthritis
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    Observation of safety, tolerability and effectiveness of adalimumab (Humira) therapy in a large patient collective under everyday clinical conditions over 2 years.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 35036
    Aachen, Germany, 52062
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35510
    Ahlen, Germany, 59227
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35040
    Ahrensburg, Germany, 22926
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35043
    Altenburg, Germany, 04600
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35046
    Altenholz, Germany, 24161
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35049
    Amberg, Germany, 92224
    Status
    Not applicable
    Showing {first} - {last} of {total} Results